These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21402550)

  • 1. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.
    Lancioni CL; Mahan CS; Johnson DF; Walusimbi M; Chervenak KA; Nalukwago S; Charlebois E; Havlir D; Mayanja-Kizza H; Whalen CC; Boom WH
    J Infect Dis; 2011 Apr; 203(7):992-1001. PubMed ID: 21402550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.
    Nanteza MW; Mayanja-Kizza H; Charlebois E; Srikantiah P; Lin R; Mupere E; Mugyenyi P; Boom WH; Mugerwa RD; Havlir DV; Whalen CC
    J Infect Dis; 2011 Sep; 204(6):884-92. PubMed ID: 21849285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens.
    da Silva TP; Giacoia-Gripp CB; Schmaltz CA; Sant Anna FM; Rolla V; Morgado MG
    PLoS One; 2013; 8(6):e66095. PubMed ID: 23840403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
    J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
    Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
    J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of interrupted anti-retroviral treatment on the reconstitution of memory and naive T cells during tuberculosis treatment in HIV patients with active pulmonary tuberculosis.
    Nalukwago S; Lancioni CL; Oketcho JB; Canaday DHE; Boom WH; Ojok L; Mayanja-Kizza H
    Afr Health Sci; 2017 Dec; 17(4):954-962. PubMed ID: 29937865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of etiotropic therapy on the immune status of patients with HIV infection and tuberculosis].
    Zimina VN; Kravchenko AV
    Ter Arkh; 2015; 87(11):37-41. PubMed ID: 26821414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
    Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
    J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
    Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment.
    Ku NS; Oh JO; Shin SY; Kim SB; Kim HW; Jeong SJ; Han SH; Song YG; Kim JM; Choi JY
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):226-30. PubMed ID: 22881387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
    Serrano-Villar S; Sainz T; Lee SA; Hunt PW; Sinclair E; Shacklett BL; Ferre AL; Hayes TL; Somsouk M; Hsue PY; Van Natta ML; Meinert CL; Lederman MM; Hatano H; Jain V; Huang Y; Hecht FM; Martin JN; McCune JM; Moreno S; Deeks SG
    PLoS Pathog; 2014 May; 10(5):e1004078. PubMed ID: 24831517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
    Komati S; Shaw PA; Stubbs N; Mathibedi MJ; Malan L; Sangweni P; Metcalf JA; Masur H; Hassim S
    AIDS; 2010 Jul; 24(12):1849-55. PubMed ID: 20622529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.
    Mahan CS; Walusimbi M; Johnson DF; Lancioni C; Charlebois E; Baseke J; Chervenak KA; Mugerwa RD; Havlir DV; Mayanja-Kizza H; Whalen CC; Boom WH;
    PLoS One; 2010 Feb; 5(2):e9138. PubMed ID: 20179751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
    Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
    HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
    Vogler MA; Teppler H; Gelman R; Valentine F; Lederman MM; Pomerantz RJ; Pollard RB; Cherng DW; Gonzalez CJ; Squires KE; Frank I; Mildvan D; Mahon LF; Schock B;
    J Acquir Immune Defic Syndr; 2004 May; 36(1):576-87. PubMed ID: 15097300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term antiretroviral therapy fails to reduce the expanded activated CCR5-expressing CD4+ T lymphocyte population or to restore the depleted naive population in chronically HIV-infected individuals with active pulmonary tuberculosis.
    Kabue JP; de Swardt D; de Beer C; Glashoff RH
    AIDS Res Hum Retroviruses; 2013 May; 29(5):769-77. PubMed ID: 23259904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
    Massanella M; Negredo E; Puig J; Puertas MC; Buzón MJ; Pérez-Álvarez N; Carrillo J; Clotet B; Martínez-Picado J; Blanco J
    AIDS; 2012 Nov; 26(18):2285-93. PubMed ID: 23018435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.